Alira Health

Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia

Complements Alira Health’s Established US and EU Mediterranean Clinical Operations with a Strong Central European Presence

FRAMINGHAM, Mass. – April 5, 2022– Alira Health, a global health care advisory and technology company, announced that it has acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and digital therapeutics. Founded in 2012, Sourcia is based in Europe, with headquarters in Zevenbergen, The Netherlands, and operational offices in Munich, Germany, and Vienna, Austria.

Benjamin Chambon

Benjamin Chambon

CCO and Co-Founder,

Alira Health

The increasing need for time-efficient and cost-effective drug development is driving demand for CRO services.  We believe that Sourcia’s integrated outsourcing model is particularly suited to the needs of today’s market,” said Benjamin Chambon, Chief Commercial Officer of Alira Health. “Sourcia is a well-established player in the European CRO market with a deeply experienced leadership team and a strong reputation in the VC community for a pattern of innovation. We are incredibly honored to welcome them to Alira Health.”

Verena Koepke

Verena Koepke

Managing Partner, Sourcia

 

Sourcia’s unique integrated outsourcing model lets biotech and MedTech clients manage clinical trials with the highest level of effectiveness, efficiency, and trust”, said Verena Koepke, Managing Partner of Sourcia. “We are extremely pleased to become part of Alira Health and expand our capabilities of full-service clinical work. Alira Health’s broad range of tech-enabled consulting and advisory services, complemented by its mission to humanize healthcare, is where our industry is headed.”

About Sourcia

Sourcia founded in 2012, is a Contract Research Organization, that specifically focuses on providing clinical trial services for Phase I to Phase IV / Pre- and Post CE marking-related clinical trials. Sourcia is located in Europe with its Headquarters in Zevenbergen, The Netherlands, and with its operational offices in Munich, Germany, and Vienna, Austria. Sourcia’s target is to focus on small-to-medium-sized biotech and medical device companies located in Europe. The team has years of practical experience and will support its clients on the road to success by finding the best-unbiased outsourcing solution for them and their businesses.

Learn more at www.sourcia.eu.

 

Related news

Events April 22, 2025
MEET2WIN 2025
Discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.
Clinical EU Oncology Real-World Evidence (RWE) Transaction Advisory
Events April 1, 2025
The Medtech Forum 2025
Connect with our experts to learn how we can help accelerate patient access to your innovations.
EU HEOR MedTech Pricing
Articles March 27, 2025
Tangible Ways Patient Insights Accelerate Access and Product Launch
This article explores how leveraging patient insights can help companies overcome market access barriers and improve their chances of success.
Patient Centricity Patient Engagement Patient-Enabled Innovation Product Development
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Articles March 17, 2025
Heart Failure Medical Devices Market Landscape in 2025
Explore the forces shaping heart failure medical devices, the emerging technologies driving innovation, and the key challenges on the road ahead.
Cardiology Medical Devices MedTech
Articles March 13, 2025
Beyond Patient Advisory Boards: Expanding Methods for Patient-Centered Insights in Healthcare
Explore innovative ways to gather patient insights for your product development beyond traditional advisor boards.
Patient Advocacy Patient Centricity Patient Engagement
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.